TABLE 2

Transport kinetics for 6-substituted pyrrolo[3,2-d]pyrimidine analogs compared with MTX, PMX, and AGF94

Transport assays were performed using engineered R2/PCFT4 (expresses PCFT only) and R1-11 RFC2 (expresses RFC only) cells. For determinations of Km and Vmax values by Lineweaver-Burk analysis, concentrations of [3H]AGF347 or [3H]MTX were from 0.02 to 0.5 μM for R2/PCFT4 (at pH 5.5) and from 0.25 to 5 µM for R1-11 RFC2 (at pH 7.2). Ki values for each of the drugs were determined by Dixon analysis over a range of concentrations of nonradioactive competitor from 0 to 500 nM (for R2/PCFT4 at pH 5.5) or 0 to 1 µM (for R1-11 RFC2 at pH 7.2) and 0.5 µM [3H]MTX. Results are presented as geometric mean values (with 95% confidence intervals) from three biologic replicates. Pairwise statistical comparisons were performed against MTX (Km and Vmax) and PMX (Ki) using two-sided, unpaired t test.

SubstrateRFC (R1-11 RFC2), pH 7.2PCFT (R2/PCFT4), pH 5.5
KmVmaxVmax/KmKiKmVmaxVmax/KmKi
µMpmol/mg per minuteµMµMpmol/mg per minuteµM
MTX0.609 (0.597–0.622)80 (44–144)118 (110–126)ND0.329 (0.245–0.441)404 (184–888)1230 (687–2204)ND
PMXNDNDND0.583 (0.513–0.663)NDNDND0.056 (0.054–0.058)
AGF94NDNDND1.614*** (1.423–1.830)NDNDND0.070ns (0.044–0.111)
AGF291NDNDND0.276** (0.225–0.338)NDNDND0.163# (0.096–0.275)
AGF320NDNDND0.200* (0.148–0.272)NDNDND0.142* (0.097–0.209)
AGF3470.388ns (0.280–0.536)72ns (68–75)205 (156–270)0.247* (0.186–0.327)0.057* (0.038–0.086)184 (129–263)3227 (1499–6945)0.070*** (0.068–0.073)
  • ND, not determined; ns, “no significant difference” when comparing parameters from MTX and AGF347.

  • # P < 0.1; *P < 0.05; **P < 0.01; ***P < 0.001.